NKCC1 is also known to regulate glioma cell volume changes by increasing [Cl−]i, which results in Cl− efflux upon GABA binding and cell shrinkage to promote glioma cell proliferation, migration, and invasion of surrounding parenchyma (Table 1; Schiapparelli et al., 2017). Here, SLC12A2 is linked to central nervous system cancer.